Senadim Senadim

Dr. Senadim Senadim

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2016 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
SSSenadim Senadim
Senadim Senadim
SBSezin Alpaydin Baslo
Sezin Alpaydin Baslo
BGBetül Tekin Güveli
Betül Tekin Güveli
MDMetin Dedei Daryan
Metin Dedei Daryan
EKElif Kantaroglu
Elif Kantaroglu
DADilek Atakli
Dilek Atakli

1 January 2018 in European Neurology
Verified
Journal Article
Closed access
PDF file
SSSenadim Senadim
Senadim Senadim
EUErsin Uygun
Ersin Uygun
MEMucahid Erdogan
Mucahid Erdogan
AKAyhan Koksal
Ayhan Koksal
ASAysun Soysal
Aysun Soysal
DADilek Atakli
Dilek Atakli
Background: The humanitarian response for Syria has been largely managed either from within Syria or from neighboring countries, particularly Turkey. This study was aimed at determining the sociodemographic and clinical profiles of Syrian asylum-seekers admitted to our clinic, changes in patient number across years, and the percentage of patients on follow-ups. Methods: Syrian patients who were admitted to the neurology outpatient clinics, neurology emergency department (ED), and hospitalized in the neurology clinics were included in the study. Age, gender, number of admissions, year of admissions, chief complaints, diagnoses, and follow-up percentages of patients were recorded. Results: The total number of Syrian patients who were first admitted to our hospital and consulted from other clinics, were found to be 763 (ED: 609 [79.8%], outpatient: 134 [17.6%] consultation: 20 [2.6%]). A total of 543 (96.1%) of the patients with a neurological disorder did not come to the follow-ups even though their conditions required regular follow-ups. The most common complaints were headache (24.2%), fainting (16.1%), weakness (11.9%), and dizziness (10%). Conclusion: Most of the patients admitted to our hospital did not come to the follow-ups and information regarding their treatments could not be obtained. Even though the Republic of Turkey provided the Syrian asylum-seekers with free medical care, utilization of these resources may be limited because of socioeconomic issues.

10 March 2016 in Archives of Neuropsychiatry
Verified
Journal Article
Closed access
SSSenadim Senadim
Senadim Senadim
DBDilek Bozkurt
Dilek Bozkurt
MCMurat Cabalar
Murat Cabalar
ABArsida Bajrami
Arsida Bajrami
VYVildan Yayla
Vildan Yayla
Almost one-third of ischemic strokes has an unknown etiology and are classified as cryptogenic stroke. Paradoxical embolism because of a patent foramen ovale (PFO) is detected in 40%-50% of these patients. Recently, PFO has been reported as a risk factor for patients of all age groups. In this study, 1080 ischemic stroke patients admitted to our clinic (2011-2013) were retrospectively evaluated. Age, sex, risk factors, complete blood count, vasculitis, biochemical and hypercoagulability tests, magnetic resonance imaging, magnetic resonance angiography, transthoracic echocardiography, transeosophageal echocardiography (TEE) findings, and therapeutic approaches were evaluated. The age range of the participants (seven male and four female patients) was 20-60 years (mean=43.09±11.13 years). Hemiparesis (n=10), diplopia (n=2), hemianopsia (n=2), and dysarthria (n=2) were the main findings of the neurological examinations. Patient medical history revealed hypertension (n=3), asthma (n=1), deep venous thrombosis (n=1), and smoking (n=4). Diffusion-weighted imaging showed middle cerebral artery (n=8) and posterior cerebral artery (n=3) infarctions. In one case, symptomatic severe carotid stenosis was detected. In eight cases, TEE showed PFO without any other abnormalities, but PFO was associated with atrial septal aneurysm in two cases, and in one case it was associated with ventricular hypokinesia and pulmonary arterial hypertension. Antiplatelet therapy was applied to nine patients and percutaneous PFO closure operation to two patients. In a 2-year follow-up, no recurrent ischemic stroke was recorded. PFO, especially in terms of the etiology of cryptogenic stroke in young patients, should not be underestimated. We want to emphasize the importance of TEE in identifying potential cardioembolic sources not only in young but also in all ischemic stroke patients with unknown etiology; we also discuss the controversial management options of PFO.

19 July 2015 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
SSSenadim Senadim
Senadim Senadim
MCMurat Cabalar
Murat Cabalar
HGHabip Gedik
Habip Gedik
AKAli Bayram Kasim
Ali Bayram Kasim
ABAnıl Bulut
Anıl Bulut
ZEZeynep Erdogdu
Zeynep Erdogdu

1 January 2020 in Medical Bulletin of Haseki
Verified
Journal Article
Closed access
RGRabia Gokcen Gozubatik-Celik
Rabia Gokcen Gozubatik-Celik
AYAyşe Yılmaz
Ayşe Yılmaz
FÇFunda Küçükali Çarkı
Funda Küçükali Çarkı
SASerap Altın
Serap Altın
EÇEda Çoban
Eda Çoban
ASAysun Soysal
Aysun Soysal

1 January 2026 in Stroke: Vascular and Interventional Neurology
Verified
Journal Article
Open access
MRManuel Requena
Manuel Requena
MOMarta Olivé-Gadea
Marta Olivé-Gadea
FDFrancesco Diana
Francesco Diana
JKJohannes Kaesmacher
Johannes Kaesmacher
AMAdnan Mujanovic
Adnan Mujanovic
ATAlejandro Tomasello
Alejandro Tomasello
BACKGROUND: In the case of failed reperfusion or severe stenosis during endovascular treatment of acute stroke, intracranial stenting is a growing practice. We aimed to study clinical and radiological outcomes in a large multicenter cohort. METHODS: The RESISTANT registry (Registry of Endovascular Salvage for Intracranial Stenting in Thrombectomy-Refractory Stroke; 2016–2023) is a multicenter single-arm retrospective registry of patients with acute stroke who underwent intracranial stenting during endovascular treatment across 36 international centers. The primary end point was functional outcome at 90 days. Secondary end points were final successful reperfusion (modified Thrombolysis in Cerebral Infarction, 2b-3) and stent patency at 24 hours. Safety outcomes included procedural complications, symptomatic intracranial hemorrhage, and in-hospital mortality. Logistic regression models including those variables that achieved statistical significance, along with age, baseline National Institutes of Health Stroke Scale, and baseline modified Rankin Scale, were used to define independent predictors. RESULTS: Among 904 patients enrolled, 876 fulfilled inclusion criteria. Median age was 67.0 (interquartile range, 59.0–77.0) years, 567 (64.8%) were men, and the median National Institutes of Health Stroke Scale score was 12.0 (interquartile range, 7.0–19.0). Anterior circulation was involved in 624 (71.6%), and the rate of tandem extracranial/intracranial occlusion was 4.9%. Stenting was performed in 469 patients (53.5%), owing to failed reperfusion (expanded Thrombolysis in Cerebral Infarction, 0-2a), and in 320 patients (36.5%) because of residual severe stenosis. After stenting, immediate successful recanalization was achieved in 777 (89.5%). At 90 days, the rate of modified Rankin Scale score of 0 to 2 was 41.2%. The number of thrombectomy attempts (adjusted odds ratio, 0.810 [95% CI, 0.707–0.929]; P =0.003) and the final successful recanalization (adjusted odds ratio, 19.394 [95% CI, 5.486–68.560]; P <0.001) were associated with good functional outcome. During admission, the reocclusion rate was 12.2%, most of them within 48 hours. Symptomatic intracranial hemorrhage was diagnosed in 8.4% of patients; no variables were independently associated with a higher probability. CONCLUSIONS: Acute intracranial stenting was a feasible therapy for patients with failed reperfusion or severe stenosis. Successful reperfusion and a lower number of thrombectomy attempts predicted functional outcome. Prospective studies are warranted to confirm efficacy and safety.